miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention.
about
Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potentialMicroRNAs, cancer and ionizing radiation: Where are we?ApoptomiRs of Breast Cancer: Basics to ClinicsmiR-24 triggers epidermal differentiation by controlling actin adhesion and cell migrationMicroRNAs Used in Combination with Anti-Cancer Treatments Can Enhance Therapy EfficacymiR-24 limits aortic vascular inflammation and murine abdominal aneurysm development.A hierarchical poisson log-normal model for network inference from RNA sequencing data.Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cellsSweating the small stuff: microRNAs and genetic changes define pancreatic cancer.Cardiovascular importance of the microRNA-23/27/24 family.Upregulation of miR-24 is associated with a decreased DNA damage response upon etoposide treatment in highly differentiated CD8(+) T cells sensitizing them to apoptotic cell death.MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis.Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseasesMiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3θ.MiR-24 promotes the survival of hematopoietic cellsSimultaneous miRNA and mRNA transcriptome profiling of human myoblasts reveals a novel set of myogenic differentiation-associated miRNAs and their target genes.MicroRNAs in apoptosis, autophagy and necroptosisPhospho-histone H2AX is a diagnostic and prognostic marker for epithelial ovarian cancerMiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity.Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.A feedback loop comprising PRMT7 and miR-24-2 interplays with Oct4, Nanog, Klf4 and c-Myc to regulate stemness.miR clusters target cellular functional complexes by defining their degree of regulatory freedom.Estrogen and retinoic acid antagonistically regulate several microRNA genes to control aerobic glycolysis in breast cancer cells.Hypoxia alters MicroRNA expression in rat cortical pericytes.MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis.Selected miRNA levels are associated with IKZF1 microdeletions in pediatric acute lymphoblastic leukemia.Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.MicroRNA-378 regulates cell proliferation and migration by repressing RNF31 in pituitary adenoma.Low-level serum miR-24-2 is associated with the progression of colorectal cancer.
P2860
Q26772219-F9B46172-4D25-40E1-AE29-9B77E38E0B35Q26782613-81F775DA-9C12-401A-910F-16E76AC6B890Q26801435-0BEFCFF9-A681-424E-B16B-7BD43AAF1C10Q28072414-56FABF8F-681A-4629-8A34-FF8537A061ABQ28277153-BB3CF714-A158-4B83-9EB1-BA4D96A87826Q28829013-0EBA03C0-EC24-4A78-860F-EBBC93A55E59Q30596758-86AC5C1A-6FF8-4CDC-B9A0-C722F8D7F6CEQ30681834-14CB7586-4AAA-4815-BFCF-40EC3D62E727Q33648268-E7151F69-7CAC-4F1A-BBFC-2DF351200C1AQ33862088-D8AE61FF-7D56-43C7-9957-D827947B903AQ34237674-438BACEB-E7C0-40E4-8BAC-452B13A8B7E5Q34262677-9DEB16B2-02CC-4D73-8F0B-D83848D8B4CFQ34278292-ECA150F6-AF57-4CFC-AA7A-DBF17F836129Q34391443-3627A2C4-2DC0-4DDB-B8CE-05C4D3048C8CQ34510548-C8A6A884-2656-4E8B-9810-C5577E7E7109Q34576525-F292AEEE-387B-4EE4-AC4D-0F10C0428BE0Q34676929-8530E9A6-9480-48EC-B7B3-259D6F484A7EQ35832148-D30FA7FA-CAB7-40FB-ADC0-7861D0E15029Q35854285-363482F8-0CD6-43A3-97AF-D3A9038770F8Q36210780-87AC90B3-C2A1-486D-8796-28D7C713D393Q36353046-9C1A4DB1-ABD3-4612-AB4A-7DECD381AD81Q37362672-6D5637F7-F3A9-4568-9052-79BD92C544D7Q37507592-826F0600-8BA7-4830-B270-9B352013108CQ38771877-F6A0A82A-D437-4A5C-AF67-3C1510F5E8DAQ39259747-9E374925-6A60-4810-9716-02558A5606F8Q40102531-3233BFCC-A3C2-4B11-93E9-42F14CDD4467Q41223735-76017B06-3113-4E40-AFD5-85691E2FA686Q41617996-BD2CB1B5-62D5-452E-965E-324094B4CC0FQ47994031-A03C5373-519B-4858-A34D-F94794C04C1CQ49209510-A4A794F7-4043-4416-A9CB-C14A7FCE8062Q49678502-2788B657-4AB4-4ED1-8546-37393857009C
P2860
miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
miR-24-2 controls H2AFX expres ...... for therapeutic intervention.
@ast
miR-24-2 controls H2AFX expres ...... for therapeutic intervention.
@en
type
label
miR-24-2 controls H2AFX expres ...... for therapeutic intervention.
@ast
miR-24-2 controls H2AFX expres ...... for therapeutic intervention.
@en
prefLabel
miR-24-2 controls H2AFX expres ...... for therapeutic intervention.
@ast
miR-24-2 controls H2AFX expres ...... for therapeutic intervention.
@en
P2093
P2860
P356
P1476
miR-24-2 controls H2AFX expres ...... l for therapeutic intervention
@en
P2093
Archita Srivastava
Niloo Srivastava
Ponnusamy Kalaiarasan
Sailesh Gochhait
Shilpi Chattopadhyay
Siddharth Manvati
P2860
P2888
P356
10.1186/BCR2861
P577
2011-04-04T00:00:00Z
P5875
P6179
1014854881